352 search results for “drug delivery” in the Staff website
-
SCALE-UP workshop by expert Jerry Feldman
Lecture, Workshop
-
Miranda van Eck new Scientific Director of the LACDR institute
As of 1 September Miranda van Eck will be the new Scientific Director of the Leiden Academic Centre for Drug Research. She succeeds Hubertus Irth, who led the institute since 2016. Van Eck has been appointed for a period of four years.
-
Await AND anticipate. How the municipality of Amsterdam manages developments in the digital public domain.
The issue of how to deal with a development such as digitalisation in the public domain raises difficult questions for the municipality: who is responsible and when do you intervene?
-
Article eLaw about Fair and equitable AI in biomedical research and healthcare
Eduard Fosch-Villaronga and Bart Custers from eLaw - Center for Law and Digital Technologies wrote an article on Fair Medicine and AI highlighting that AI for biomedical research and healthcare should be beneficent and equitable for everyone.
-
Hadassah Drukarch presents at the Fair Medicine and AI conference
At the International Online Conference 'Fair Medicine and Artificial Intelligence' organised by the University of Tübingen (Germany), Hadassah Drukarch, junior researcher at eLaw, gave a presentation on how current algorithmic-based systems may reinforce biases in healthcare. This topic forms part of…
-
A promising marriage between Siemens and Leiden spin-off Culgi
Siemens recently took over the Leiden software company Culgi, founded by professor and inventor J.G.E.M. (Hans) Fraaije. We spoke to him about the algorithm that made him successful, the role of a university in our society and his ambitions at Siemens. ‘I was looking for Siemens, and they were looking…
-
Regilme wins a 2022 Human Rights Publication Accolade from American Sociological Association
Salvador Santino Regilme received Honorable Mention for the 2022 Best Scholarly Article Award from the Sociology of Human Rights Section of the American Sociological Association (ASA). He won for his paper “Visions of Peace Amidst a Human Rights Crisis: War on Drugs in Colombia and the Philippines,”…
-
Atherosclerosis resembles an autoimmune disease. Marie Depuydt graduated on this topic, with honours
In addition to cholesterol and high blood pressure as risk factors for atherosclerosis, we may need to address our own immune system to prevent a heart attack or stroke. Marie Depuydt revealed which cells exactly reside in the atherosclerotic plaque that narrows an artery. The presence of a diverse…
-
Gilles van Wezel steps down as SD of the IBL: Hubertus Irth appointed as temporary replacement
Gilles van Wezel will step down as Scientific Director (WD) of the Institute of Biology Leiden (IBL) as of June 17th. He has held this position since September 2018. Van Wezel will be temporarily succeeded by Hubertus Irth, the current WD of the Leiden Academic Centre for Drug Research (LACDR). Irth…
-
‘Pharmacogenetics will become part of patient care’
Does medicine make patients feel better or worse? We are getting better at predicting this from people’s DNA profiles, says Professor Jesse Swen. ‘It never fails to fascinate me how one DNA base pair can have such a huge effect on treatment with medication and the outcome.’
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Students seek sustainable solutions for businesses
Master’s students in Industrial Ecology and Governance of Sustainability have helped answer organisations’ questions about sustainability
-
Maternal mortality in the Netherlands halved in recent years
The number of women in the Netherlands dying before, during or after childbirth has halved.
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
Master student Nicole ter Laak wins third “Dr. Saal van Zwanenberg research price”
Nicole ter Laak (Master student Biopharmaceutical sciences) has won the third price of the “Dr Saal van Zwanenberg research price”. The award ceremony is on 14 November.
-
Gerrard Boot on abuses in parcel industry
Three directors of PostNL have been arrested in Belgium, suspected of human trafficking among other things. Abuses also exist in the Dutch parcel delivery sector. Why does the Netherlands act less firmly?
-
New publication: Papyrological Texts and Studies in Honour of Peter van Minnen
This volume contains the edition or re-edition of 52 papyri and ostraca, dating from between the third century BCE and the eighth century CE.
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Requesting facilities for working from home
If you work at home on a structural basis – at least one day a week – and you have an employment contract for 19 hours or more, you can request facilities for working from home
-
Lipsius
Cleveringaplaats 1, Leiden
-
Calling on universities and funders: make research information open
Crucial information about research, funding or how university rankings are created is often not freely accessible. The Barcelona Declaration on Open Research Information calls for such information to be made open. Professor Ludo Waltman is one of its initiators. What needs to change?
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Salvador Santino Regilme awarded fellowship at NIAS
Salvador Santino Regilme has been selected for a fellowship at the Netherlands Institute for Advanced Study (NIAS) in Amsterdam. From September 2022, he will spend 5 months at NIAS working on his research project titled 'The Normative Order of the Global War on Drugs'.
-
Willem Jespers wins the international Rottendorf Foundation Award for Pharmacy and Pharmacology 2023
Willem Jespers was awarded the international prize, worth €10,000, for pharmacy and pharmacology from the Rottendorf foundation on October 13th 2023 at the University of Münster. He was recognized for his research in the field of computer-aided drug development and the prediction of drug toxicities.…
-
LACDR EMA Lunchtalk
On Friday the 29th of October, LACDR presented highlights of its research and teaching program during an online Lunchtime Talk session at the European Medicines Agency (EMA).
-
Successful symposium on Circuit Topology
On the 8th of December 2021, Leiden Academic Centre for Drug Research (LACDR) organized “Circuit Topology 2021”, the first international symposium on circuit topology. The focus was on the mathematical notion of Circuit Topology, and its applications to physics, chemistry and biomedicine.
-
Versatile antiviral proteins discovered with supercomputer
A single tiny molecule that can destroy flu, corona, HIV and Zika viruses? Yes, it really does exist. Biophysicist Niek van Hilten, who will receive his doctorate on 14 September, contributed to this discovery.
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster and better, scientists across the country are joining forces. The Next Generation ImmunoDermatology (NGID) project, with LACDR professor Robert Rissmann…
-
Leiden Revisited: terug in de collegebanken!
Tijdens Leiden Revisited kregen alumni van de Rechtenfaculteit de mogelijkheid om zich weer even echt student te voelen. Dit jaar vond het evenement namelijk plaats in de (oude) vertrouwde collegebanken van het Kamerlingh Onnes Gebouw.
-
Read the three most downloaded papers by CADS researchers
Three of our researchers have been awarded a certificate for receiving enough downloads to be in the top 10% of papers in 2022
-
Referral options
If you’re unsure where to refer students to for well-being support, this page should help. It provides an overview of the support available at Leiden University.
-
3 October University: ‘Artificial intelligence is like young people and sex’
‘Everyone’s talking about it, everyone thinks everyone else is doing it, but the reality is disappointing,’ says biochemist Gerard van Westen in his 3 October University lecture in the Van der Werfpark. In the full marquee, he gets a laugh with this suggestion that artificial intelligence is comparable…
-
Podcast: A changing view on Psychedelics
We talk with Michiel van Elk, about his research into mapping what effects psychedelics have on the human brain and what this means for the possible clinical application of these drugs. The cognitive psychologist shares his findings with a sober view, bringing critics and fanatics closer together for…
-
Wanda van der Stel - ALTEX Prize Winner 2022
The members of the Board of ALTEX Edition, the ALTEX Editorial Board and ALTEX Editorial Office elect the winner of the annual award out of all main articles published in the previous year; articles including members of the Board of ALTEX Edition or ALTEX Editorial Office as first authors are excluded.…
-
ERC-grant for Sebastian Pomplun to cure disease by controlling gene expression with synthetic transcription factors
Sebastian Pomplun receives an ERC starting grant of 1.85 million Euros in five years. He wants to develop synthetic transcription factors that can enter cells and activate or deactivate specific genes. For example to disrupt cancer-related processes or to trigger the production of an important missing…
-
Awarded research project Next Generation ImmunoDermatology: Towards Biomarker-driven Dermatology practice in the Netherlands
The Dutch Research Council (NWO) has, within the framework of Research along Routes by Consortia (NWA-ORC), awarded the research project Next Generation Immuno-Dermatology (NGID) with a prestigious grant of 11.7 MEuro. NGID is a nationwide, large-scale project to unravel novel biomarkers for six different…
-
Developing new therapies to fight muscle disease
Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…
-
Construction projects
If you wish to find out about current construction projects, you will find an up-to-date overview of Leiden University construction projects below.
-
Deadline library acquisition requests upcoming semester: 31 July 2023
Library
- Summer opening hours at Oude UB, Gravensteen and the Academy Building
-
Mark Leiser part of winning consortium of €1.5 million Volkswagen Foundation research grant
Dr Mark Leiser, Assistant Professor in Law and Digital Technologies at eLaw, is part of a successful €1.5 million bid for a research grant from the acclaimed Volkswagen Institute on “Reclaiming individual autonomy and democratic discourse online: How to rebalance human and algorithmic decision makin…
-
LACDR Fall Symposium 2022
On November 1, the LACDR Fall Symposium took place. After the symposium was opend by prof.dr. Hubertus Irth, the program started with a lecture called “Poly(2-oxazoline)s, structural chameleons in therapeutic delivery” given by key note speaker dr. Joachim van Guyse.
-
Eric De Brabandere: 'Both Ukraine and Russia have an interest in a ceasefire'
Last week Russia and Ukraine met for the first time since the outbreak of the war. The talks took place in Belarus.